Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB)

CUSIP: 034569103

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Common Stock
Shares outstanding
41,587,315
Total 13F shares
4,677,847
Share change
+487,435
Total reported value
$24,324,000
Price per share
$5.20
Number of holders
8
Value change
+$2,192,344
Number of buys
3
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 034569103?
CUSIP 034569103 identifies ANEB - Anebulo Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) as of Q2 2022

As of 30 Jun 2022, Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,677,847 shares. The largest 8 holders included 22NW, LP, LVW Advisors, LLC, MANGROVE PARTNERS, Ikarian Capital, LLC, BOOTHBAY FUND MANAGEMENT, LLC, BlackRock Inc., Tower Research Capital LLC (TRC), and UBS Group AG. This page lists 8 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.